Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes

Diabetes Research and Clinical Practice

Volumn 82, Issue 2, 2008, Pages 233-237

  Imagawa, Akihisa ^a,k   Hanafusa, Toshiaki ^a,k   Iwahashi, Hiromi ^b,k   Uchigata, Yasuko ^c,k   Kanatsuka, Azuma ^d,k   Kawasaki, Eiji ^e,k   Kobayashi, Tetsuro ^f,k   Shimada, Akira ^g,k   Shimizu, Ikki ^h,k   Maruyama, Taro ^i,k   Makino, Hideichi ^j,k  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d Chiba Central Medical Center   (Japan)

^e NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^f UNIVERSITY OF YAMANASHI   (Japan)

^g KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

ⁱ Saitama Social Insurance Hospital   (Japan)

^j EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k The Research Committee of Fulminant Type 1 Diabetes in the Japan Diabetes Society   (Japan)

more..

Author keywords

Child; Idiopathic; Phenotype; Pregnancy; Pubertal

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CHILD; CLINICAL FEATURE; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HLA-DR ANTIGENS; HUMANS; INFANT; JAPAN; MALE; MIDDLE AGED; PREGNANCY; SEX FACTORS; YOUNG ADULT;

EID: 54549117907     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.08.003     Document Type: Article

References (8)

1. Eisenbarth G.S., Polonsky K.S., and Buse J.B. Williams Textbook of Endocrinology, 10th ed., Type 1 Diabetes Mellitus (2003), Saunders, Philadelphia pp. 1485-1504
2. Imagawa A., Hanafusa T., Miyagawa J., Matsuzawa Y., and for the Osaka IDDM study group. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N. Engl. J. Med. 342 (2000) 301-307
3. Imagawa A., Hanafusa T., Uchigata Y., Kanatsuka A., Kawasaki E., Kobayashi T., et al. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care 26 (2003) 2345-2352
4. Hanafusa T., and Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 36-45
5. Imagawa A., Hanafusa T., Uchigata Y., Kanatsuka A., Kawasaki E., Kobayashi T., et al. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 48 (2005) 294-300
6. Shimizu I., Makino H., Imagawa A., Iwahashi H., Uchigata Y., Kanatsuka A., et al. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J. Clin. Endocrinol. Metab. 91 (2006) 471-476
7. Ministry of Health, Labour and Welfare. National survey of health and nutrition in 2005, 2006 http://www.mhlw.go.jp/toukei/list/61-17.html (in Japanese).
8. Takaike H., Uchigata Y., Iwasaki N., and Iwamoto Y. Transient elevation of liver transaminase after starting insulin therapy for diabetic ketosis or ketoacidosis in newly diagnosed type 1 diabetes mellitus. Diabetes Res. Clin. Pract. 64 (2004) 27-32